Argent Trust CO Gilead Sciences, Inc. Transaction History

Argent Trust CO

$2.39 Billion
Q3 2024

A detailed history of Argent Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Argent Trust CO holds 68,927 shares of GILD stock, worth $6.3 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

68,927

Previous 74,074 6.95%

Holding current value

$6.3 Million

Previous $5.08 Million 13.68%

% of portfolio

0.24%

Previous 0.23%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $342,738 - $432,296	-5,147 Reduced 6.95%	68,927 $5.78 Million
Q2 2024 Aug 12, 2024	SELL	$63.15 - $72.88 $233,907 - $269,947	-3,704 Reduced 4.76%	74,074 $5.08 Million
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $65,996 - $80,481	-922 Reduced 1.17%	77,778 $5.7 Million
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $1.21 Million - $1.37 Million	-16,460 Reduced 17.3%	78,700 $6.38 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $430,330 - $469,499	5,820 Added 6.51%	95,160 $7.13 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $521,884 - $595,282	6,866 Added 8.33%	89,340 $6.89 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $385,235 - $438,902	-4,983 Reduced 5.7%	82,474 $6.84 Million
Q4 2022 Feb 10, 2023	SELL	$62.32 - $89.47 $2,492 - $3,578	-40 Reduced 0.05%	87,457 $7.51 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $137,716 - $157,307	2,313 Added 2.72%	87,497 $5.4 Million
Q2 2022 Aug 11, 2022	BUY	$57.72 - $65.01 $398,902 - $449,284	6,911 Added 8.83%	85,184 $5.27 Million
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $307,902 - $385,835	5,316 Added 7.29%	78,273 $4.65 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $32,829 - $37,261	506 Added 0.7%	72,957 $5.3 Million
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $222,632 - $240,195	-3,289 Reduced 4.34%	72,451 $5.06 Million
Q2 2021 Aug 09, 2021	SELL	$63.47 - $69.35 $147,313 - $160,961	-2,321 Reduced 2.97%	75,740 $5.22 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $965,580 - $1.1 Million	16,093 Added 25.97%	78,061 $5.05 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $8,214 - $9,359	-145 Reduced 0.23%	61,968 $3.61 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $887,409 - $1.12 Million	14,290 Added 29.88%	62,113 $3.93 Million
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $752,408 - $873,684	-10,401 Reduced 17.86%	47,823 $3.68 Million
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $240,749 - $308,365	3,844 Added 7.07%	58,224 $4.35 Million
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $34,568 - $38,024	561 Added 1.04%	54,380 $3.53 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $704,612 - $777,768	11,272 Added 26.49%	53,819 $3.41 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $62,364 - $69,935	1,008 Added 2.43%	42,547 $2.87 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $15,069 - $16,882	-241 Reduced 0.58%	41,539 $2.7 Million
Q4 2018 Feb 06, 2019	SELL	$60.54 - $79.0 $85,421 - $111,469	-1,411 Reduced 3.27%	41,780 $2.61 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $72,634 - $80,419	-1,019 Reduced 2.3%	43,191 $3.29 Million
Q2 2018 Apr 15, 2019	BUY	$64.88 - $75.68 $69,097 - $80,599	1,065 Added 2.47%	44,210 $3.13 Million
Q2 2018 Aug 15, 2018	BUY	$64.88 - $75.68 $2.22 Million - $2.58 Million	34,150 Added 379.66%	43,145 $3.06 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $78,157 - $95,282	-1,073 Reduced 10.66%	8,995 $678,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $57,204 - $67,150	-804 Reduced 7.4%	10,068 $722,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $783,979 - $929,229	10,872	10,872 $881,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account